Mannatech (MTEX) Competitors $10.45 -0.57 (-5.17%) As of 04/30/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MTEX vs. XCUR, ANL, GNTA, SAVA, IMAB, IZTC, ACOG, IVVD, JSPR, and PYXSShould you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include Exicure (XCUR), Adlai Nortye (ANL), Genenta Science (GNTA), Cassava Sciences (SAVA), I-Mab (IMAB), Invizyne Technologies (IZTC), Alpha Cognition (ACOG), Invivyd (IVVD), Jasper Therapeutics (JSPR), and Pyxis Oncology (PYXS). These companies are all part of the "pharmaceutical products" industry. Mannatech vs. Exicure Adlai Nortye Genenta Science Cassava Sciences I-Mab Invizyne Technologies Alpha Cognition Invivyd Jasper Therapeutics Pyxis Oncology Mannatech (NASDAQ:MTEX) and Exicure (NASDAQ:XCUR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, community ranking, valuation, media sentiment, institutional ownership, risk, earnings and dividends. Which has preferable earnings & valuation, MTEX or XCUR? Mannatech has higher revenue and earnings than Exicure. Exicure is trading at a lower price-to-earnings ratio than Mannatech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMannatech$117.87M0.17-$2.24M$1.337.86Exicure$500K132.05-$16.91M-$4.81-2.17 Is MTEX or XCUR more profitable? Exicure has a net margin of 0.00% compared to Mannatech's net margin of -1.26%. Mannatech's return on equity of -15.62% beat Exicure's return on equity.Company Net Margins Return on Equity Return on Assets Mannatech-1.26% -15.62% -3.76% Exicure N/A -190.90%-36.75% Does the MarketBeat Community believe in MTEX or XCUR? Mannatech received 318 more outperform votes than Exicure when rated by MarketBeat users. Likewise, 77.49% of users gave Mannatech an outperform vote while only 47.37% of users gave Exicure an outperform vote. CompanyUnderperformOutperformMannatechOutperform Votes32777.49% Underperform Votes9522.51% ExicureOutperform Votes947.37% Underperform Votes1052.63% Does the media prefer MTEX or XCUR? In the previous week, Mannatech had 1 more articles in the media than Exicure. MarketBeat recorded 3 mentions for Mannatech and 2 mentions for Exicure. Exicure's average media sentiment score of 1.43 beat Mannatech's score of 0.96 indicating that Exicure is being referred to more favorably in the news media. Company Overall Sentiment Mannatech Positive Exicure Positive Do institutionals and insiders hold more shares of MTEX or XCUR? 13.0% of Mannatech shares are owned by institutional investors. Comparatively, 42.8% of Exicure shares are owned by institutional investors. 41.5% of Mannatech shares are owned by company insiders. Comparatively, 3.9% of Exicure shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, MTEX or XCUR? Mannatech has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Exicure has a beta of 3.74, meaning that its stock price is 274% more volatile than the S&P 500. SummaryMannatech beats Exicure on 9 of the 15 factors compared between the two stocks. Get Mannatech News Delivered to You Automatically Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MTEX vs. The Competition Export to ExcelMetricMannatechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.87M$1.19B$5.57B$7.82BDividend YieldN/AN/A5.11%4.22%P/E Ratio-12.9010.4522.4218.48Price / Sales0.1710.33394.10103.91Price / CashN/A10.4038.1834.62Price / Book1.851.456.774.25Net Income-$2.24M-$54.34M$3.22B$248.23M7 Day Performance7.73%11.77%3.25%3.29%1 Month Performance18.35%22.62%0.01%2.42%1 Year Performance26.27%-38.98%18.00%5.54% Mannatech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MTEXMannatech1.6167 of 5 stars$10.45-5.2%N/A+26.3%$19.87M$117.87M-12.90250Short Interest ↓XCURExicure2.1826 of 5 stars$11.30+33.9%N/A+1,925.2%$71.39M$500,000.00-5.4650Short Interest ↓Gap UpANLAdlai Nortye2.609 of 5 stars$1.93+0.8%$9.00+367.5%-86.7%$71.03M$5M0.00127Short Interest ↓News CoveragePositive NewsGNTAGenenta Science2.09 of 5 stars$3.87-0.3%$25.00+546.0%+26.3%$70.97MN/A0.007Short Interest ↑News CoverageGap DownSAVACassava Sciences3.6369 of 5 stars$1.46+1.4%$54.50+3,632.9%-93.0%$70.53MN/A-1.0630IMABI-Mab2.7459 of 5 stars$0.86+1.2%$5.50+543.3%-46.9%$69.68M$3.27M0.00380Short Interest ↑News CoverageIZTCInvizyne TechnologiesN/A$10.84-2.5%N/AN/A$67.77MN/A0.00N/AGap UpACOGAlpha Cognition2.2952 of 5 stars$4.21+2.2%$20.00+375.1%N/A$67.44MN/A-1.64N/ANews CoverageGap UpIVVDInvivyd3.6207 of 5 stars$0.56+10.0%$7.52+1,239.9%-71.6%$67.30M$25.38M-0.29100Upcoming EarningsShort Interest ↓News CoveragePositive NewsGap DownJSPRJasper Therapeutics2.3028 of 5 stars$4.44+11.8%$62.50+1,307.7%-77.0%$66.70MN/A-0.9420News CoveragePositive NewsPYXSPyxis Oncology1.528 of 5 stars$1.06+10.0%$9.20+767.9%-75.3%$65.29M$16.15M-1.0360 Related Companies and Tools Related Companies XCUR Alternatives ANL Alternatives GNTA Alternatives SAVA Alternatives IMAB Alternatives IZTC Alternatives ACOG Alternatives IVVD Alternatives JSPR Alternatives PYXS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MTEX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mannatech, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Mannatech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MTEX Stock Free MTEX Stock Alerts